Randomized, Double‐Blind, Placebo Controlled Study of Methylphenidate for the Treatment of Depression in SSRI‐Treated Cancer Patients Receiving Palliative Care

ConclusionsThis trial failed to demonstrate that methylphenidate treatment in SSRI‐treated patients had a significant effect on depression remission in advanced cancer patients. This study underscores the difficulties in conducting trials for symptom management in patients with shortened life expectancy.

Source: Psycho-Oncology - June 30, 2016 Category: Cancer & Oncology Authors: Donald R. Sullivan, Solange Mongoue‐Tchokote, Motomi Mori, Elizabeth Goy, Linda Ganzini Tags: PAPER Source Type: research